Related Experiment Video
Updated: Aug 11, 2026
06:40
Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Proposed drug-drug cost effectiveness methodology
Jean Paul Gagnon1, Jane T Osterhaus
1Pharmacy Administration, School of Pharmacy, University of North Carolina, Beard Hall 200H, Chapel Hill, 27514, USA.
The Annals of Pharmacotherapy
|March 2, 2006
Summary
Hospital administrators must compare drug costs and benefits. This paper presents a cost-effectiveness analysis methodology for evaluating similar drugs, aiding formulary decisions.
Area of Science:
- Health Economics
- Pharmaceutical Policy
Background:
- Prospective reimbursement models necessitate rigorous cost-benefit analyses for hospital drug selection.
- Evaluating similar drugs with comparable therapeutic outcomes presents significant challenges for healthcare decision-makers.
Discussion:
- This paper reviews existing drug-drug cost-effectiveness procedures.
- A methodology is outlined for comparing the cost-effectiveness of drugs with similar therapeutic profiles.
- Data acquisition from clinical studies and company sources for spreadsheet analysis is detailed.
Key Insights:
- Cost-effectiveness analysis provides a structured approach to drug evaluation.
- The proposed methodology facilitates informed decision-making for hospital formulary committees.
- Utilizing electronic spreadsheets enhances the efficiency of drug cost-benefit analysis.
Outlook:
- Standardizing cost-effectiveness analysis can improve resource allocation in hospitals.
- Further research could refine methodologies for complex drug comparisons.
- The integration of cost-effectiveness data into formulary management systems is recommended.
Related Concept Videos
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...